Norges Bank acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor acquired 730,567 shares of the company’s stock, valued at approximately $66,927,000.
Other institutional investors have also made changes to their positions in the company. Torren Management LLC bought a new stake in shares of HealthEquity in the fourth quarter valued at approximately $40,000. Northwestern Mutual Wealth Management Co. boosted its stake in shares of HealthEquity by 190.4% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 604 shares of the company’s stock valued at $55,000 after buying an additional 396 shares during the period. AlphaQuest LLC boosted its stake in shares of HealthEquity by 52.2% in the third quarter. AlphaQuest LLC now owns 624 shares of the company’s stock valued at $59,000 after buying an additional 214 shares during the period. Larson Financial Group LLC boosted its stake in shares of HealthEquity by 24.4% in the third quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after buying an additional 123 shares during the period. Finally, Allworth Financial LP boosted its stake in shares of HealthEquity by 88.3% in the fourth quarter. Allworth Financial LP now owns 706 shares of the company’s stock valued at $65,000 after buying an additional 331 shares during the period. 99.55% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
Several equities research analysts recently issued reports on HQY shares. Deutsche Bank Aktiengesellschaft boosted their price target on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, March 19th. Barclays cut their price target on HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a research note on Wednesday, February 18th. BMO Capital Markets upgraded HealthEquity from a “market perform” rating to an “outperform” rating and boosted their price target for the company from $85.00 to $105.00 in a research note on Thursday, April 9th. Royal Bank Of Canada boosted their price target on HealthEquity from $100.00 to $108.00 and gave the company an “outperform” rating in a research note on Wednesday. Finally, KeyCorp reiterated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $110.57.
HealthEquity Stock Up 3.1%
Shares of HQY opened at $88.67 on Friday. HealthEquity, Inc. has a one year low of $72.76 and a one year high of $113.80. The company has a market cap of $7.41 billion, a P/E ratio of 33.21, a P/E/G ratio of 1.51 and a beta of 0.21. The company has a debt-to-equity ratio of 0.46, a current ratio of 3.44 and a quick ratio of 3.44. The firm has a 50 day simple moving average of $84.05 and a two-hundred day simple moving average of $86.33.
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings data on Thursday, May 28th. The company reported $1.24 EPS for the quarter, beating the consensus estimate of $1.11 by $0.13. HealthEquity had a net margin of 17.25% and a return on equity of 14.75%. The business had revenue of $354.64 million during the quarter, compared to the consensus estimate of $352.02 million. HealthEquity’s quarterly revenue was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts forecast that HealthEquity, Inc. will post 3.93 EPS for the current fiscal year.
Insider Buying and Selling at HealthEquity
In other HealthEquity news, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president directly owned 91,141 shares in the company, valued at $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction that occurred on Friday, May 29th. The shares were sold at an average price of $95.00, for a total transaction of $298,490.00. Following the transaction, the executive vice president owned 59,113 shares of the company’s stock, valued at approximately $5,615,735. This represents a 5.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 13,081 shares of company stock worth $1,193,000 over the last three months. Corporate insiders own 1.60% of the company’s stock.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Articles
- Five stocks we like better than HealthEquity
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
